| Name | Title | Contact Details |
|---|
Invisible is the operations innovation company transforming how companies are built and run. Our tech-enabled service harnesses our proprietary process orchestration platform, which seamlessly blends AI and automation with a global team of over 2000 highly-skilled agents. This integration eliminates execution bottlenecks and opens up new efficiency, scale, and growth possibilities for clients, delivering any operations capability better, faster, and cheaper than traditional 20th century services companies.
Palisade Insurance Partners is a global managing general underwriter (MGU) dedicated to underwriting, structuring and insuring specialty risks. We focus on providing insurance solutions for litigation and other contingent risks that are instrumental in helping insureds manage and transfer risk associated with legal, tax, and transactional situations. We provide straightforward solutions for complex situations, while always maintaining our core values of independence and integrity.
IMUNON is a fully integrated, clinical stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the bodys natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases. IMUNON has two platform technologies: Our TheraPlas® platform for the development of immunotherapies and other anti-cancer nucleic acid-based therapies and our PLACCINE platform for the development of nucleic acid vaccines for infectious diseases and cancer. The Companys lead clinical program, GEN-1, is a DNA-based immunotherapy for the localized treatment of advanced ovarian cancer currently in Phase II development. GEN-1 works by instructing the body to produce safe and durable levels of powerful cancer fighting molecules, such as interleukin-12 (IL-12) and interferon gamma (IFN-γ), at the tumor site. In addition, we are conducting pre-clinical proof-of-concept studies on a nucleic acid vaccine candidate targeting SARS-CoV-2 virus in order to validate our PLACCINE platform. IMUNONs platform technologies are based on the delivery of nucleic acids with novel synthetic delivery systems that are independent of viral vectors or devices. We will continue to leverage these platforms and to advance the technological frontier of plasmid DNA to better serve patients with difficult to treat conditions.
Unlock Your Business Creativity with AI-accelerated Content Productivity. We leverage our BPR know-how and unique bottled marketing and operation expertise to help business leaders receive deeper insights using Gen AI. Embrace the AI-assisted revolution with TFS custom deep prompts, GPTs for ChatGPT Team, and individualized consulting to improve efficiency, effectiveness, and quality. Our team combines decades of expertise with a pioneering spirit. We understand AI is a transformative technology, but we also recognize the irreplaceable value of human insight and oversight. Our offerings blend the strengths of people and machines through prompt engineering, consulting, and subscription-based access to our AI knowledge base. Depending on your specific needs, one of our experts will lead your project. Contact us at info@TheFusionSyndicate.com today to learn more. ***Privacy Statement*** We value your privacy and are committed to keeping your personal information secure. We will never sell your data to a third party and will only use it to contact you regarding our services. Rest assured that we will handle your information with the utmost care and confidentiality.